Source:http://linkedlifedata.com/resource/pubmed/id/20410659
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2010-4-22
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0015-5691
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
135
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
159-68
|
| pubmed:dateRevised |
2011-7-27
|
| pubmed:meshHeading |
pubmed-meshheading:20410659-Amides,
pubmed-meshheading:20410659-Animals,
pubmed-meshheading:20410659-Antihypertensive Agents,
pubmed-meshheading:20410659-Fumarates,
pubmed-meshheading:20410659-Humans,
pubmed-meshheading:20410659-Hypertension,
pubmed-meshheading:20410659-Male,
pubmed-meshheading:20410659-Rats
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
[The pharmacological profile and clinical findings on aliskiren (Rasilez tablet), direct renin inhibitor].
|
| pubmed:affiliation |
motoharu.tanaka@novartis.com
|
| pubmed:publicationType |
Journal Article,
Review
|